A California biotechnology firm has voluntarily withdrawn an enzyme product from the market after losing a patent infringement lawsuit to Novozymes. Genencor International Inc., a Palo Alto, Calif.-based subsidiary of Danisco, has halted sales of Spezyme Ethyl, an alpha amylase enzyme. The decision follows a federal judge's ruling in a Delaware court that Genencor was selling enzymes protected by Novozymes' patent rights to the American ethanol market. Novozymes said in a written statement Friday that damages have yet to be decided in the case but that the company currently claims "several million" dollars for loss of profits. Novozymes, which was spun off from Novo Nordisk in 2000, develops enzymes for use in the manufacture of cellulosic-based ethanol.

Posted by GEN-ERIC at 12:19:18 am into the following categories: In The News

---

http://gen-eric.com/patents/htsrv/trackback.php/819

Name:

Email: (not displayed on this site)

Site/Url:

Comment text:

Allowed XHTML tags: <p, ul, ol, li, dl, dt, dd, address, blockquote, ins, del, a, span, bdo, br, em, strong, dfn, code, samp, kdb, var, cite, abbr, acronym, q, sub, sup, tt, i, b, big, small>

URLs, email, AIM and ICQs will be converted automatically.

Options:
Auto-BR (Line breaks become <br />)
Remember me (Set cookies for name, email & url)